| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.5 | 0.07 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.07 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.095 | 0.08 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |